MODERATOR
:
SPEAKER
(S):
Christine Fernandez, RN, BSN, Vice President, Co-Director, PhereSys Therapeutics, Inc.
Colleen McGuinness Slapak, MS, MT(ASCP)SBB, Transfusion Safety Director, Community Blood Center/Community Tissue Services
Description
Through case study presentations, attendees will be able to participate in discussion of an incidence of TRALI from donation to hospital follow-up post-transfusion reaction, donor/patient undergoing hematopoietic progenitor cell collection, and patient receiving therapeutic apheresis.
-
Describe the implications of TRALI from the perspectives of the donor, the blood center, the hospital, and the recipient.
-
Determine the care plan and clinical/technical implications of a patient receiving therapeutic apheresis therapy.
-
Discuss the care plan and clinical/technical implications of a patient/donor undergoing hematopoietic progenitor cell collections.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
2 |
California Nurse |
2.4 |
Florida Laboratory Personnel |
2.4 |
General Attendee |
2 |
Physician |
2 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.